l carnitine and liver disease Deficiency: What Is It, Causes, Symptoms, More and alcoholic fatty liver disease

The new peptide targets a protein called Mcl-1, which helps cancer cells avoid the cellular suicide that is usually induced by DNA damage

The convenience of oral capsules, combined with bioavailability comparable to injection, makes this a practical choice for many

Disclosures: Allison Carroll: Nothing to Disclose, Wolfram Goessling: Nothing to Disclose, Marc Sherman: Nothing to Disclose 2430 FXR AGONIST INT-787 INHIBITS INFLAMMATION, FIBROSIS, SENESCENCE, AND APOPTOSIS ARREST IN HUMAN CHOLANGIOCYTES MODELING PSC Francesca De Franco 1 Daniela Passeri 1 Sanjay Kansra 2 Luciano Adorini 2 Mary Erickson 2 Roberto Pellicciari 1 , 1 TES Pharma S.r.l., Perugia, Italy, 2 Intercept Pharmaceuticals, Inc., Morristown, New Jersey, USA Background: Cholangiocyte senescence is present in all stages of primary sclerosing cholangitis (PSC) and is associated with disease severity

From Fig